Detalles de la búsqueda
1.
Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres.
Bioorg Med Chem Lett
; 24(15): 3609-13, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24913714
2.
Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors.
Bioorg Med Chem Lett
; 23(11): 3262-6, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23602398
3.
Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
Bioorg Med Chem Lett
; 22(2): 1068-72, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22182499
4.
A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors.
Bioorg Med Chem Lett
; 22(1): 65-70, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22169260
5.
Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats.
Brain Res
; 977(2): 221-30, 2003 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-12834882
6.
The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Endocrinology
; 150(7): 3101-9, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19324999
Resultados
1 -
6
de 6
1
Próxima >
>>